MedAware vs TheraDoc (2026)
A learned model against a rules engine, in the same pharmacy department. TheraDoc watches live laboratory, microbiology, pharmacy and admission feeds and raises alerts for stewardship, infection prevention and anticoagulation, all of it driven by rules the hospital's own staff wrote and can read. MedAware detects prescriptions that do not fit the patient, using unsupervised outlier detection over longitudinal data, and it exists because a rules based system could not express the error that killed a child. These are layers rather than alternatives: the rules catch the known hazard and generate the override fatigue, and the outlier model catches what no rule anticipated. Ask TheraDoc how its rules are validated and retired, and MedAware how its model performs across the populations you actually treat.
- It detects prescribing outliers a rule library cannot express, using unsupervised outlier detection over longitudinal patient data rather than pairwise checks.
- The evidence was produced mainly by investigators independent of the company, including a Harvard Medical School group, which is rare for a machine learning product here.
- It exists because a rule based system missed the error that killed a child, which is a precise statement of what it adds.
- It covers infection prevention with mandatory reporting, antimicrobial stewardship, pharmacy surveillance and anticoagulation in one platform.
- The security page names specific credentials including national health information technology certification and third party vulnerability testing.
- Alerts route to a clinical pharmacist or infection preventionist who investigates, and the platform never touches an order.
This comparison is published by AI Health Index, an independent research platform that compares healthcare AI vendors objectively. MedAware and TheraDoc are each graded against the same capability taxonomy, from each vendor's own public materials and the regulatory record, under the AI Health Index verification standard. No vendor pays for placement, and no vendor has reviewed this page. How this evidence is graded
Plain facts
| Fact | MedAware | TheraDoc |
|---|---|---|
| Primary category | Medication Safety & Prescribing | Medication Safety & Prescribing |
| Founded | 2012 | 1999 |
| Headquarters | Ra'anana, Israel | Salt Lake City, Utah, United States |
| Website | medaware.com | solutions.premierinc.com |
Side by Side
Each record in one paragraph
Written to be quoted whole. Each paragraph states what the AI Health Index verified about the vendor, with the caveats attached. Generated from this pair’s live capability grades, so it moves when a grade moves.
The AI Health Index awards MedAware its top capability grade on AI Centrality. Set against TheraDoc, MedAware grades higher on AI Centrality and Clinical and Operational Evidence. Its thinnest published disclosure sits on several axes, including Model Supply Chain Disclosure, HIPAA and BAA Posture and Security Certifications and Trust Center. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
The AI Health Index records no top capability grade for TheraDoc on any axis it scores. Set against MedAware, TheraDoc grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. Its thinnest published disclosure sits on AI Centrality, AI Governance and Bias Disclosure and Commercial Transparency. Grades reflect evidence the AI Health Index could verify at the last review, so a low grade records disclosure the vendor has not published rather than a capability it has been shown to lack.
Source: AI Health Index, August 2026
Questions buyers ask
Should we choose MedAware or TheraDoc?
On the axes where the AI Health Index separates them, MedAware grades higher on AI Centrality and Clinical and Operational Evidence, and TheraDoc grades higher on several axes, including Model and Technology Transparency, Model Supply Chain Disclosure and AI Safety and PHI Stewardship. TheraDoc leads on the greater share of scored axes, but the split means the decision turns on which constraint is binding rather than on an overall winner.
Where do MedAware and TheraDoc differ most?
The widest separation the AI Health Index records between MedAware and TheraDoc is on AI Centrality, where MedAware grades A and TheraDoc grades D. That axis sits in the AI Capability group, so it should carry the most weight for a buyer whose binding constraint is how much of the work the model itself is trusted to do.
Where do MedAware and TheraDoc grade the same?
The AI Health Index grades MedAware and TheraDoc the same on several axes, including Autonomy and Oversight Model, FDA and Regulatory Status and AI Governance and Bias Disclosure. Neither holds an advantage the index can evidence on those axes, so they should not carry weight in a selection between these two.
What have MedAware and TheraDoc not disclosed?
At the last review, at least one of MedAware and TheraDoc published thin or absent detail on several axes, including AI Centrality, Model Supply Chain Disclosure and HIPAA and BAA Posture. The AI Health Index treats an absent disclosure as a gap in the public record rather than a failure of the product, so these are the axes to get in writing during diligence instead of inferring from the grade.
Related comparisons
Other published head to head assessments involving these vendors or their closest peers. The full set for this category is on the Clinical Decision Support page.
The important distinction is that one engine evaluates rules the hospital's own staff wrote and the other learns what normal looks like, so the diligence questions differ: rule validation methodology and retirement cadence for the surveillance platform, and subgroup performance for the outlier model, since what counts as anomalous depends on the population the model learned from. MedAware publishes no subgroup performance by age, sex, race, ethnicity, insurance status or site, and neither vendor publishes a security attestation of the higher type or pricing.